Status:
ENROLLING_BY_INVITATION
Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
Lead Sponsor:
Vanderbilt University
Conditions:
Nonalcoholic Fatty Liver Disease
Eligibility:
FEMALE
18-65 years
Brief Summary
Nonalcoholic fatty liver disease (NAFLD) is the most common type of liver disease in the United States. The incidence of NAFLD is very similar to that of obesity, type 2 diabetes, and the metabolic sy...
Eligibility Criteria
Inclusion
- 18-65 year of age
- Undergoing elective abdominal or bariatric surgery
- May have normal or elevated ALT/AST levels
Exclusion
- Presence of viral hepatitis
- Significant alcohol use
- Intercurrent infections
- Use of any thiazolidinediones
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00983463
Start Date
October 1 2009
End Date
November 1 2026
Last Update
December 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232